GSDMB and pancreatic adenocarcinoma: Surprisingly, high promoter methylation levels of GSDMB are related to poor prognosis of KIRC patients, similar to UCEC, LUAD, and PAAD, which showed contrasting clinical outcomes based on GSDMB expression.